JSTL
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
(In Cr.) |
---|
(In Cr.) | ||||
---|---|---|---|---|
This data is currently unavailable for this company. |
(In %) |
---|
(In Cr.) |
---|
Financial Year (In Cr.) |
---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
Jeevan Scientific Technology Issue Of Up To 3.5 Million Warrants At 40 Rupees Each
Oct 15 (Reuters) - Jeevan Scientific Technology JEEV.BO:
ISSUE OF UP TO 3.5 MILLION WARRANTS AT 40 RUPEES EACH
ISSUE OF UP TO 4.2 MILLION SHARES AT 40 RUPEES EACH
Source text: ID:nBSE2l6ThM
Further company coverage: JEEV.BO
(([email protected];))
Oct 15 (Reuters) - Jeevan Scientific Technology JEEV.BO:
ISSUE OF UP TO 3.5 MILLION WARRANTS AT 40 RUPEES EACH
ISSUE OF UP TO 4.2 MILLION SHARES AT 40 RUPEES EACH
Source text: ID:nBSE2l6ThM
Further company coverage: JEEV.BO
(([email protected];))
Jeevan Scientific Technology Completes CDSCO Inspections Of Clinical And Bioanalytical Facilities
April 9 (Reuters) - Jeevan Scientific Technology Ltd JEEV.BO:
JSTL COMPLETES CDSCO INSPECTIONS OF CLINICAL AND BIOANALYTICAL FACILITIES
INSPECTIONS CONCLUDED SUCCESSFULLY WITH OBSERVATIONS/RECOMMENDATIONS
Source text: ID:nBSE8whCfP
Further company coverage: JEEV.BO
(([email protected];;))
April 9 (Reuters) - Jeevan Scientific Technology Ltd JEEV.BO:
JSTL COMPLETES CDSCO INSPECTIONS OF CLINICAL AND BIOANALYTICAL FACILITIES
INSPECTIONS CONCLUDED SUCCESSFULLY WITH OBSERVATIONS/RECOMMENDATIONS
Source text: ID:nBSE8whCfP
Further company coverage: JEEV.BO
(([email protected];;))
Jeevan Scientific Technology Says USFDA Conducted Inspection At Bioanalytical Facility At Manikonda
Feb 23 (Reuters) - Jeevan Scientific Technology Ltd JEEV.BO:
USFDA CONDUCTED AN INSPECTION OF OUR BIOANALYTICAL FACILITY, AT MANIKONDA
INSPECTOR CLOSED THE INSPECTION WITH NO 483
Source text for Eikon: ID:nBSE4rL8Mw
Further company coverage: JEEV.BO
(([email protected];))
Feb 23 (Reuters) - Jeevan Scientific Technology Ltd JEEV.BO:
USFDA CONDUCTED AN INSPECTION OF OUR BIOANALYTICAL FACILITY, AT MANIKONDA
INSPECTOR CLOSED THE INSPECTION WITH NO 483
Source text for Eikon: ID:nBSE4rL8Mw
Further company coverage: JEEV.BO
(([email protected];))
Jeevan Scientific Technology Says Unit Entered Into Co-Development Agreement With Aditri Pharma Sciences
Oct 18 (Reuters) - Jeevan Scientific Technology Ltd JEEV.BO:
UNIT ENTERED INTO CO-DEVELOPMENT AGREEMENT WITH ADITRI PHARMA SCIENCES
CO-DEVELOPMENT AGREEMENT TO DEVELOP CERTAIN PHARMACEUTICAL PREPARATIONS ON 50:50 BASIS
Further company coverage: JEEV.BO
(([email protected];))
Oct 18 (Reuters) - Jeevan Scientific Technology Ltd JEEV.BO:
UNIT ENTERED INTO CO-DEVELOPMENT AGREEMENT WITH ADITRI PHARMA SCIENCES
CO-DEVELOPMENT AGREEMENT TO DEVELOP CERTAIN PHARMACEUTICAL PREPARATIONS ON 50:50 BASIS
Further company coverage: JEEV.BO
(([email protected];))
Events:
Dividend
Dividend
More Nano Cap Ideas
See similar 'Nano' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Jeevan Scientific do?
Established in 1999, Jeevan Scientific Technology (JSTL) is a leading player in the field of Clinical Research since 2014. It offers quality and cost-effective services to Pharma and Biotech companies worldwide, leveraging technology, innovation, and expertise.
Who are the competitors of Jeevan Scientific?
Jeevan Scientific major competitors are Vivo Bio Tech, Zenotech Laboratorie, Sun Pharma Adv. Res, Dishman Carbogen Amc, Syngene Internation., Hikal, Suven Life Sciences. Market Cap of Jeevan Scientific is ₹105 Crs. While the median market cap of its peers are ₹4,212 Crs.
Is Jeevan Scientific financially stable compared to its competitors?
Jeevan Scientific seems to be less financially stable compared to its competitors. Altman Z score of Jeevan Scientific is 4.73 and is ranked 4 out of its 8 competitors.
Does Jeevan Scientific pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Jeevan Scientific latest dividend payout ratio is 15.11% and 3yr average dividend payout ratio is 15.11%
How has Jeevan Scientific allocated its funds?
Companies resources are majorly tied in miscellaneous assets
How strong is Jeevan Scientific balance sheet?
Balance sheet of Jeevan Scientific is strong. It shouldn't have solvency or liquidity issues.
Is the profitablity of Jeevan Scientific improving?
The profit is oscillating. The profit of Jeevan Scientific is -₹4.18 Crs for TTM, -₹1.3 Crs for Mar 2024 and -₹3.05 Crs for Mar 2023.
Is the debt of Jeevan Scientific increasing or decreasing?
Yes, The net debt of Jeevan Scientific is increasing. Latest net debt of Jeevan Scientific is ₹14.9 Crs as of Mar-25. This is greater than Mar-24 when it was ₹10.18 Crs.
Is Jeevan Scientific stock expensive?
Jeevan Scientific is not expensive. Latest PE of Jeevan Scientific is 0.0, while 3 year average PE is 70.81. Also latest EV/EBITDA of Jeevan Scientific is 49.96 while 3yr average is 56.19.
Has the share price of Jeevan Scientific grown faster than its competition?
Jeevan Scientific has given better returns compared to its competitors. Jeevan Scientific has grown at ~6.51% over the last 8yrs while peers have grown at a median rate of -0.78%
Is the promoter bullish about Jeevan Scientific?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Jeevan Scientific is 38.05% and last quarter promoter holding is 38.05%.
Are mutual funds buying/selling Jeevan Scientific?
There is Insufficient data to gauge this.